Xie Feng, Sheng Shuya, Ram Venkatesh, Pandit Hemant
Department of Orthopedics, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, Leeds, UK.
Arthroplast Today. 2024 Jul 23;28:101399. doi: 10.1016/j.artd.2024.101399. eCollection 2024 Aug.
One of the most debated topics in modern total knee arthroplasty (TKA) is the impact of metal hypersensitivity (MH) as a potential cause of prosthesis failure. Implanting hypoallergenic prostheses to avoid potential problems in suspected cases of MH is one treatment option that can be used in such cases. However, their long-term clinical safety and efficacy are not well proven.
All literature relevant to modern hypoallergenic implants were reviewed and summarized to provide a comprehensive synopsis. In addition, a detailed literature search was performed on PUBMED, MEDLINE, and Google Scholar to identify all the clinical studies reporting outcomes for hypoallergenic knee implants. Our search was confined to those studies published as full manuscripts in the English language from July 2018 to July 2023.
To minimize the risk of MH, new implant variants have been developed which are either under clinical evaluation or in routine clinical use. These include conventional metal implants with protective coatings (mono- or multilayer) and metal-free implants. However, there is insufficient clinical data to confirm the rationale and effectiveness of using these "hypoallergenic" TKA implants.
Published studies and arthroplasty registry data analyses indicate no significant differences between hypoallergenic and standard TKAs with overall good survival rates. In the future, further high-quality studies are needed to better understand the complexity of this subject.
金属超敏反应(MH)作为假体失败的潜在原因,是现代全膝关节置换术(TKA)中最具争议的话题之一。在疑似MH病例中植入低过敏性假体以避免潜在问题是一种可用于此类情况的治疗选择。然而,它们的长期临床安全性和有效性尚未得到充分证实。
对所有与现代低过敏性植入物相关的文献进行回顾和总结,以提供全面的概述。此外,在PubMed、MEDLINE和谷歌学术上进行了详细的文献检索,以确定所有报告低过敏性膝关节植入物结果的临床研究。我们的检索仅限于2018年7月至2023年7月以英文全文发表的那些研究。
为了将MH风险降至最低,已经开发出了新的植入物变体,这些变体要么正在进行临床评估,要么已在常规临床中使用。这些包括带有保护涂层(单层或多层)的传统金属植入物和无金属植入物。然而,没有足够的临床数据来证实使用这些“低过敏性”TKA植入物的原理和有效性。
已发表的研究和关节成形术登记数据分析表明,低过敏性TKA和标准TKA之间没有显著差异,总体生存率良好。未来,需要进一步的高质量研究来更好地理解这个问题的复杂性。